<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang Z</submitter><funding>Sir Jules Thorn Charitable Trust</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Harvard Medical School</funding><funding>National Institute for Health Research (NIHR)</funding><funding>UK National Institute of Health Research Cambridge Biomedical Research Centre</funding><funding>National Institutes of Health</funding><funding>Wellcome Trust</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><pagination>1311-1327</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6547869</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>216(6)</volume><pubmed_abstract>Interleukin-2, which conveys essential signals for immunity, operates through a heterotrimeric receptor. Here we identify human interleukin-2 receptor (IL-2R) β chain (&lt;i>IL2RB&lt;/i>) gene defects as a cause of life-threatening immune dysregulation. We report three homozygous mutations in the &lt;i>IL2RB&lt;/i> gene of eight individuals from four consanguineous families that cause disease by distinct mechanisms. Nearly all patients presented with autoantibodies, hypergammaglobulinemia, bowel inflammation, dermatological abnormalities, lymphadenopathy, and cytomegalovirus disease. Patient T lymphocytes lacked surface expression of IL-2Rβ and were unable to respond to IL-2 stimulation. By contrast, natural killer cells retained partial IL-2Rβ expression and function. IL-2Rβ loss of function was reca</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance.</pubmed_title><pmcid>PMC6547869</pmcid><funding_grant_id>101908/Z/13/Z</funding_grant_id><funding_grant_id>ACF-2019-01-004</funding_grant_id><funding_grant_id>083650/Z/07/Z</funding_grant_id><funding_grant_id>207556/Z/17/Z</funding_grant_id><funding_grant_id>GO2955/1-1</funding_grant_id><funding_grant_id>099966/Z/12/Z</funding_grant_id><funding_grant_id>12/JTA</funding_grant_id><pubmed_authors>McDonald D</pubmed_authors><pubmed_authors>Haller W</pubmed_authors><pubmed_authors>Rooryck C</pubmed_authors><pubmed_authors>Sinclair J</pubmed_authors><pubmed_authors>Pennamen P</pubmed_authors><pubmed_authors>Al-Mousa H</pubmed_authors><pubmed_authors>Acres M</pubmed_authors><pubmed_authors>Alajlan H</pubmed_authors><pubmed_authors>James JR</pubmed_authors><pubmed_authors>Smith KGC</pubmed_authors><pubmed_authors>Engelhardt KR</pubmed_authors><pubmed_authors>Gothe F</pubmed_authors><pubmed_authors>Mata CP</pubmed_authors><pubmed_authors>Modis Y</pubmed_authors><pubmed_authors>Brothers S</pubmed_authors><pubmed_authors>Naudion S</pubmed_authors><pubmed_authors>Doffinger R</pubmed_authors><pubmed_authors>Notarangelo LD</pubmed_authors><pubmed_authors>Lenardo MJ</pubmed_authors><pubmed_authors>Yamazaki Y</pubmed_authors><pubmed_authors>Hambleton S</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Alazami AM</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Bowen C</pubmed_authors><pubmed_authors>Thaventhiran JE</pubmed_authors><pubmed_authors>Matthews HF</pubmed_authors><pubmed_authors>Pelluard F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance.</name><description>Interleukin-2, which conveys essential signals for immunity, operates through a heterotrimeric receptor. Here we identify human interleukin-2 receptor (IL-2R) β chain (&lt;i>IL2RB&lt;/i>) gene defects as a cause of life-threatening immune dysregulation. We report three homozygous mutations in the &lt;i>IL2RB&lt;/i> gene of eight individuals from four consanguineous families that cause disease by distinct mechanisms. Nearly all patients presented with autoantibodies, hypergammaglobulinemia, bowel inflammation, dermatological abnormalities, lymphadenopathy, and cytomegalovirus disease. Patient T lymphocytes lacked surface expression of IL-2Rβ and were unable to respond to IL-2 stimulation. By contrast, natural killer cells retained partial IL-2Rβ expression and function. IL-2Rβ loss of function was reca</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2026-05-04T05:42:17.979Z</modification><creation>2025-05-18T13:33:29.954Z</creation></dates><accession>S-EPMC6547869</accession><cross_references><pubmed>31040185</pubmed><doi>10.1084/jem.20182304</doi></cross_references></HashMap>